<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib44">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kam</surname>
    <given-names>YW</given-names>
   </name>
   <name>
    <surname>Kien</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Roberts</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Cheung</surname>
    <given-names>YC</given-names>
   </name>
   <name>
    <surname>Lamirande</surname>
    <given-names>EW</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>SL</given-names>
   </name>
   <name>
    <surname>Tse</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Guarner</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Zaki</surname>
    <given-names>SR</given-names>
   </name>
   <name>
    <surname>Subbarao</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Peiris</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Nal</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Altmeyer</surname>
    <given-names>R</given-names>
   </name>
  </person-group>
  <year>2007</year>
  <article-title>Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro</article-title>
  <source>Vaccine</source>
  <volume>25</volume>
  <fpage>729</fpage>
  <lpage>740</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2006.08.011</pub-id>
  <?supplied-pmid 17049691?>
  <pub-id pub-id-type="pmid">17049691</pub-id>
 </element-citation>
</ref>
